One-year randomized controlled trial and follow-up of integrated neurocognitive therapy for schizophrenia outpatients

Daniel R Mueller, Stefanie J Schmidt, Volker Roder, Daniel R Mueller, Stefanie J Schmidt, Volker Roder

Abstract

Objective: Cognitive remediation (CR) approaches have demonstrated to be effective in improving cognitive functions in schizophrenia. However, there is a lack of integrated CR approaches that target multiple neuro- and social-cognitive domains with a special focus on the generalization of therapy effects to functional outcome.

Method: This 8-site randomized controlled trial evaluated the efficacy of a novel CR group therapy approach called integrated neurocognitive therapy (INT). INT includes well-defined exercises to improve all neuro- and social-cognitive domains as defined by the Measurement And Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative by compensation and restitution. One hundred and fifty-six outpatients with a diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV-TR or ICD-10 were randomly assigned to receive 15 weeks of INT or treatment as usual (TAU). INT patients received 30 bi-weekly therapy sessions. Each session lasted 90min. Mixed models were applied to assess changes in neurocognition, social cognition, symptoms, and functional outcome at post-treatment and at 9-month follow-up.

Results: In comparison to TAU, INT patients showed significant improvements in several neuro- and social-cognitive domains, negative symptoms, and functional outcome after therapy and at 9-month follow-up. Number-needed-to-treat analyses indicate that only 5 INT patients are necessary to produce durable and meaningful improvements in functional outcome.

Conclusions: Integrated interventions on neurocognition and social cognition have the potential to improve not only cognitive performance but also functional outcome. These findings are important as treatment guidelines for schizophrenia have criticized CR for its poor generalization effects.

© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Figures

Fig. 1.
Fig. 1.
Flow diagram of subject progress through phases of the randomized controlled trial for the integrated Neurocognitive Therapy (INT) and Treatment As Usual (TAU) group.

References

    1. Kern RS, Glynn SM, Horan WP, Marder SR. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull. 2009;35:347–361.
    1. Kopelowicz A, Liberman RP, Ventura J, Zarate R, Mintz J. Neurocognitive correlates of recovery from schizophrenia. Psychol Med. 2005;35:1165–1173.
    1. Liberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv. 2005;56:735–742.
    1. Jääskeläinen E, Juola P, Hirvonen N, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39:1296–1306.
    1. Shivashankar S, Telfer S, Arunagiriraj J, et al. Has the prevalence, clinical presentation and social functioning of schizophrenia changed over the last 25 years? Nithsdale schizophrenia survey revisited. Schizophr Res. 2013;146:349–356.
    1. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia. Schizophr Bull. 2000;26:119–136.
    1. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41–51.
    1. Shamsi S, Lau A, Lencz T, et al. Cognitive and symptomatic predictors of functional disability in schizophrenia. Schizophr Res. 2011;126:257–264.
    1. Roder V, Mueller DR. Integrated neurocognitive therapy for schizophrenia patients. Berlin, Springer International Publishing, the Netherlands; 2015.
    1. Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 3rd ed. 3. Band: Kinische Psychiatrie. Leipzig: Barth; 1913.
    1. Green MF, Nuechterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res. 2004;72:1–3.
    1. Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008;165:214–220.
    1. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203–213.
    1. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72:29–39.
    1. Brothers L. The social brain: a project for integrating primate behavior and neurophysiology in a new domain. Concepts Neurosci. 1990;1:27–51.
    1. Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005;31:882–887.
    1. Green MF, Penn DL, Bentall R, et al. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull. 2008;34:1211–1220.
    1. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Bio behav Rev. 2011;35:573–588.
    1. Ventura J, Wood RC, Hellemann GS. Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis. Schizophr Bull. 2013;39:102–111.
    1. Mancuso F, Horan WP, Kern RS, Green MF. Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res. 2011;125:143–151.
    1. Horan WP, Green MF, DeGroot M, et al. Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull. 2012;38:865–872.
    1. Irani F, Seligman S, Kamath V, Kohler C, Gur RC. A meta-analysis of emotion perception and functional outcomes in schizophrenia. Schizophr Res. 2012;137:203–211.
    1. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168:472–485.
    1. Grynszpan O, Perbal S, Pelissolo A, et al. Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychol Med. 2011;41:163–173.
    1. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164:1791–1802.
    1. Kurtz MM, Richardson CL. Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. Schizophr Bull. 2012;38:1092–1104.
    1. Keefe RSE, Vinogradov S, Medalia A, et al. Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. Schizophr Bull. 2011;37:1057–1056.
    1. Schmidt SJ, Mueller DR, Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull. 2011;37(suppl 2):41–54.
    1. Eack SM, Greenwald DP, Hogarty SS, et al. Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv. 2009;60:1468–1476.
    1. Horan WP, Kern RS, Tripp C, et al. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res. 2011;45:1113–1122.
    1. Lindenmayer JP, McGurk SR, Khan A, et al. Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediation. Schizophr Bull. 2013;39:507–517.
    1. Sacks S, Fisher M, Garrett C, et al. Combining computerized social cognitive training with neuroplasticity-based auditory training in schizophrenia. Clin Schizophr Relat Psychoses. 2013;7:78–86.
    1. Roder V, Brenner HD, Kienzle N, Hodel B.Integriertes Psychologisches Therapieprogram fur schizophrene Patienten (IPT). Munich: Psychologie Verlags Union; 1988.
    1. Brenner HD, Roder V, Hodel B, Kienzle N, Reed D, Liberman RP.Integrated psychological therapy for schizophrenic patients (IPT). Seattle, WA: Hogrefe & Huber Publishers; 1994.
    1. Roder V, Mueller DR, Brenner HD, Spaulding W.Psychological Therapy (IPT) for the Treatment of Neurocognition, Social Cognition and Social Competency in Schizophrenia Patients. Seattle, WA: Hogrefe & Huber; 2010.
    1. Roder V, Mueller DR, Mueser KT, Brenner HD. Integrated psychological therapy (IPT) for schizophrenia: is it effective? Schizophr Bull. 2006;32(suppl 1):81–93.
    1. Roder V, Mueller DR, Schmidt SJ. Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull. 2011;37(suppl 2):71–79.
    1. Mueller DR, Schmidt SJ, Roder V. Integrated psychological therapy: effectiveness in schizophrenia inpatient settings related to patients’ age. Am J Geriatr Psychiatry. 2013;21:231–241.
    1. Wykes T, Huddy V. Cognitive remediation for schizophrenia: it is even more complicated. Curr Opin Psychiatry. 2009;22:161–167.
    1. Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36:48–70.
    1. Fiszdon JM, Reddy LF. Review of social cognitive treatments for psychosis. Clin Psychol Rev. 2012;32:724–740.
    1. Mueller DR, Roder V. Integrated psychological therapy and integrated neurocognitive therapy (INT). In: Roder V, Medalia A, eds. Neurocognition and Social Cognition in Schizophrenia Patients. Basic Concepts and Treatment. Basel, Switzerland: Karger; 2010:118–144.
    1. Mueller DR, Schmidt SJ, Roder V. Integrated neurocognitive therapy. In: Roberts DL, Penn DL, eds. Social cognition in schizophrenia. From evidence to treatment. New York: Oxford; 2013:311–334.
    1. Roder V, Mueller —Integrierte neurokognitive Therapie bei schizophren Erkrankten. Berlin, Heidelberg: Springer; 2013.
    1. Keefe RS, Vinogradov S, Medalia A, et al. Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. Schizophr Bull. 2011;37:1057–1065.
    1. Dahl G.WIP: Handbuch zum Reduzierten Wechsler-Intelligenztest; Anwendung, Auswertung, statistische Analysen, Normwerte. Weinheim, Germany: Beltz; 1986.
    1. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skill. 1958;8:271–276.
    1. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia. 1968;6:53–60.
    1. Knye M, Roth N, Westhus W, Heine A.Continuous Performance Test (CPT). Göttingen, Germany: Hogrefe; 2003.
    1. Brickenkamp R, Liepmann D, Schmidt-Atzert L.Test d2-Revision: Aufmerksamkeits-und Konzentrationstest. Göttingen, Germany: Hogrefe; 2010.
    1. Lezak MD.Neuropsychological Assessment. 2nd ed. New York, NY: Oxford University Press; 2004.
    1. Härting C, Markowitsch H, Neufeld H, Calabrese P, Deisinger K, Kessler J.WMS-R Wechsler Gedächtnistest—Revidierte Fassung. Bern, Switzerland: Hans Huber; 2000.
    1. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry. 1997;54:159–165.
    1. Loong J.W.K. (1989). Wisconsin Card Sorting Test (WCST). La Luna Court, San Luis Obisbo: Wang Neuropsychological Laboratory.
    1. Frommann N, Streit M, Wölwer W. Remediation of facial affect recognition impairment in patient with schizophrenia: A new training program. Psychiatry Res. 2003;117;281–284.
    1. Bähler M.Evaluation eines neu entwickelten Fragebogen zur Emotionserkennung bei schizophren Erkrankten. Masterarbeit: Université de Fribourg, Suisse; 2012.
    1. Ekman P, Friesen WV, Press CP.Pictures of facial affect. Palo Alto: Consulting Psychologists Press; 1975.
    1. Vauth R, Rüsch N, Wirtz M, Corrigan PW. Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia? Psychiatry Res. 2004;128:155–165.
    1. Combs DR, Penn DL, Wicher M, Waldheter E. The Ambiguous Intentions Hostility Questionnaire (AIHQ): a new measure for evaluating hostile social-cognitive biases in paranoia. Cogn Neuropsychiatry. 2007;12:128–143.
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276.
    1. Startup M, Jackson MC, Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol. 2002;41:417–422.
    1. Nakagawa S. A farewell to Bonferroni: the problem of low statistical power and publication bias. Behav Ecol. 2004;15:1044–1045.
    1. Rustenbach SJ.Metaanalyse. Eine anwendungsorientierte Einführung. Bern, Switzerland: Huber; 2003.
    1. Bowie CR, McGurk SR, Mausbach B, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry. 2012;169:710–718.
    1. Furukawa TA, Leucht S. How to obtain NNT from Cohen’s d: comparison of two methods. PLoS One. 2011;6:e19070.
    1. Cohen J.Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, MI: Routledge; 1988.
    1. Fisher M, Holland C, Merzenich MM, Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry. 2009;166:805–811.
    1. Dias EC, Butler PD, Hoptman MJ, Javitt DC. Early sensory contributions to contextual encoding deficits in schizophrenia. Arch Gen Psychiatry. 2011;68:654–664.
    1. De Jong JJ, de Gelder B, Hodiamont PG. Sensory processing, neurocognition, and social cognition in schizophrenia: towards a cohesive cognitive model. Schizophr Res. 2013;146:209–216 .
    1. Fanning JR, Bell MD, Fiszdon JM. Is it possible to have impaired neurocognition but good social cognition in schizophrenia? Schizophr Res. 2012;135:68–71.
    1. Cole DA, Maxwell SE. Testing mediational models with longitudinal data: questions and tips in the use of structural equation modeling. J Abnorm Psychol. 2003;112:558–577.
    1. Little TD.Longitudinal Structural Equation Modeling. New York, London: The Guilford Press; 2013.
    1. Rassovsky Y, Horan WP, Lee J, Sergi MJ, Green MF. Pathways between early visual processing and functional outcome in schizophrenia. Psychol Med. 2011;41:487–497.
    1. Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012;69:1216–1224.
    1. Schmidt SJ, Müller DR, Roder V. The importance of cognition, negative symptoms and subjective parameters for functional recovery in schizophrenia. 13th International Congress on Schizophrenia Research ICOSR, Colorado Springs, 2–6 April 2011. Schizophr Bull. 2011;37(suppl 1):281–282.
    1. Roberts DL, Penn DL. Social cognition and interaction training in outpatients with schizophrenia: a preliminary study. Psychiatry Res. 2009;166:141–147.
    1. Eack SM, Mesholam-Gately RI, Greenwald DP, Hogarty SS, Keshavan MS. Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy. Psychiatry Res. 2013;209:21–26.
    1. Choi KH, Saperstein AM, Medalia A. The relationship of trait to state motivation: the role of self-competency beliefs. Schizophr Res. 2012;139:73–77.
    1. Grant PM, Beck AT. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull. 2009;35:798–806.
    1. Basco MR, Bostic JQ, Davis D, Rush AJ, Witte B, Hendrickse W, Barnett V. Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry. 2000;157:1599–1605.
    1. Robertson DA, Hargreaves A, Kelleher EB, et al. Social dysfunction in schizophrenia: an investigation of the GAF scale’s sensitivity to deficits in social cognition. Schizophr Res. 2013;146:363–365.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere